Globus Medical Quarterly Income Statement
NYSE: GMEDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Globus Medical revenue and earnings
In the quarter ended Jun 30, 2026, Globus Medical generated $789.6 million in revenue, up 5.9% from the same quarter a year earlier. Net income was $151.6 million (-25.3% year over year), for a net margin of 19.2% versus a median of 16.4% in the prior 5 quarters. Gross margin was 69.4% (up from 66.6%) and operating margin 23.1%.
Diluted earnings per share came in at $1.10, down from $1.49.
Summary generated from market data by MetaCap's automated system. Methodology
Globus Medical income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 789.61M | 759.85M | 826.42M | 769.05M | 745.34M | 598.12M | 657.29M | 625.71M | 629.69M | 606.67M | 616.53M | 383.64M |
| Revenue growth (YoY) | +5.94% | +27.04% | +25.73% | +22.91% | +18.37% | -1.41% | +6.61% | +63.10% | +115.93% | +119.26% | +124.60% | +50.95% |
| Cost of Revenue | 241.44M | 234.07M | 261.11M | 252.53M | 248.76M | 195.40M | 263.44M | 270.51M | 260.04M | 241.49M | 265.49M | 135.39M |
| Gross Profit | 548.17M | 525.79M | 565.31M | 516.51M | 496.58M | 402.72M | 393.86M | 355.19M | 369.65M | 365.18M | 351.05M | 248.25M |
| Operating Expenses | 365.74M | 375.40M | 395.97M | 379.15M | 420.47M | 305.72M | 333.58M | 307.09M | 320.03M | 357.18M | 340.93M | 247.84M |
| Research & Development | 36.32M | 36.51M | 36.16M | 38.07M | 39.95M | 33.06M | 33.41M | 35.38M | 37.70M | 57.27M | 52.25M | 29.33M |
| Selling, General & Admin | 286.82M | 297.77M | 318.48M | 313.60M | 303.62M | 242.80M | 253.17M | 240.06M | 239.45M | 248.68M | 245.15M | 156.21M |
| Operating Income | 182.43M | 150.39M | 169.34M | 137.36M | 76.11M | 97.00M | 60.27M | 48.10M | 49.62M | 8.00M | 10.12M | 404.00K |
| Other Income (Expense) | 7.38M | 6.69M | -107.00K | 6.63M | 112.06M | 6.66M | -35.61M | 8.93M | -2.04M | -16.55M | 14.87M | 2.13M |
| Pretax Income | 189.82M | 157.07M | 169.23M | 143.99M | 188.17M | 103.67M | 24.67M | 57.03M | 47.58M | -8.56M | 24.99M | 2.54M |
| Income Tax | 38.25M | 32.77M | 28.64M | 25.03M | -14.67M | 28.21M | -1.84M | 5.20M | 15.82M | -1.44M | 9.96M | 1.54M |
| Net Income | 151.57M | 124.30M | 140.59M | 118.97M | 202.85M | 75.46M | 26.50M | 51.84M | 31.76M | -7.12M | 15.03M | 998.00K |
| Net Income growth (YoY) | -25.28% | +64.72% | +430.44% | +129.50% | +538.68% | — | +76.30% | +5093.99% | -44.97% | -114.49% | -69.97% | -97.90% |
| EPS (Basic) | 1.12 | 0.92 | 1.05 | 0.88 | 1.50 | 0.55 | 0.20 | 0.38 | 0.23 | -0.05 | 0.02 | 0.01 |
| EPS (Diluted) | 1.10 | 0.90 | 1.01 | 0.88 | 1.49 | 0.54 | 0.19 | 0.38 | 0.23 | -0.05 | 0.01 | 0.01 |
| Shares Outstanding (Basic) | 135.05M | 135.36M | — | 134.50M | 135.21M | 136.76M | — | 135.62M | 135.19M | 135.36M | — | 113.54M |
| Shares Outstanding (Diluted) | 137.38M | 138.19M | — | 135.39M | 136.50M | 139.77M | — | 138.06M | 136.98M | 135.36M | — | 115.25M |
| EBITDA | 251.93M | 220.24M | 238.35M | 208.91M | 146.74M | 162.66M | 127.87M | 115.05M | 113.21M | 63.26M | 82.08M | 37.79M |
| Gross Margin | 69.42% | 69.20% | 68.41% | 67.16% | 66.62% | 67.33% | 59.92% | 56.77% | 58.70% | 60.19% | 56.94% | 64.71% |
| Operating Margin | 23.10% | 19.79% | 20.49% | 17.86% | 10.21% | 16.22% | 9.17% | 7.69% | 7.88% | 132.00% | 1.64% | 11.00% |
| Net Margin | 19.20% | 16.36% | 17.01% | 15.47% | 27.22% | 12.62% | 4.03% | 8.28% | 5.04% | -117.00% | 2.44% | 26.00% |
This table shows 12 quarterly periods of Globus Medical's income statement, from Q2 2026 back to Q3 2023, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow GMED's reporting calendar. What is a income statement?